DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 26, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.

The entire rule text may be found here:  https://www.federalregister.gov/articles/2014/08/22/2014-19922/schedules-of-controlled-substances-rescheduling-of-hydrocodone-combination-products-from-schedule

Frequently Asked Questions regarding this change may be found here: Hydrocodone FAQs



More Latest News

Emergency Rule On Gluteal Fat Grafting Effective June 27, 2019
July 9, 2019

Click here to view the Board of Medicine’s emergency rule that clarifies the standard of care for gluteal fat grafting. Continue reading


Nonopioid Alternatives Pamphlet
July 2, 2019

Click here to access the pamphlet for “Information on Nonopioid Alternatives for the Treatment of Pain” Continue reading